Thymosin Beta-15
Thymosin Beta-15 (Tβ15)
A thymosin beta family member overexpressed in prostate cancer. Promotes cell migration and invasion. Being studied as a cancer biomarker.
Mechanism of Action
Thymosin Beta-15 sequesters G-actin and promotes cell motility. Its overexpression in prostate cancer correlates with tumor aggressiveness and metastatic potential.
Health Claims & Evidence
Biomarker for prostate cancer aggressiveness
Modulates cell migration
Research tool for cancer biology
Short-Term Effects
Cell migration modulation.
Long-Term Effects
Research use primarily.
Side Effects
Potential tumor promotion — not for self-administration.
Contraindications
Not for self-administration. Potential oncogenic effects.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
Thymosin beta-15 and prostate cancer
Bao et al. · Nature Medicine · 1996
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Thymosin Beta-15 and related peptides, and prepare an educational research summary.
Explore Research